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INTRODUCTION
Preeclampsia is a condition unique to human pregnancy.
Occurring in 5-7% of pregnancies, it is the major cause of
maternal and perinatal morbidity and mortality, but the patho-
genesis of this disorder has not been clearly established.
Recently, an excessive maternal systemic inflammatory
response to pregnancy has been proposed to be responsible
for endothelial dysfunction leading to cellular activation and/
or damage (1). Endothelial dysfunction is considered to be
central in the pathogenesis of preeclampsia (2, 3). The inflam-
matory process is the adhesion of leukocytes to endothelial
cells followed by transmigration of these cells into perivascu-
lar tissue. Leukocyte endothelial adhesion is governed largely
by the interaction of adhesion molecules and their ligands on
these cells. A number of the molecules which mediate leuko-
cyte-endothelial adhesion have been identified; these include
vascular cellular adhesion molecule-1 (VCAM-1), intracellular
adhesion molecule-1 (ICAM-1) and E-selectin (4-6). In vitro
studies have shown that the expression of these molecules on
the endothelial surface is tightly regulated, and that this reg-
ulation may have a crucial role in the nature of leukocyte re-
cruitment during the course of an inflammatory response (7). 
Soluble forms of these molecules may be released to the cir-
culation, and increased serum levels of these molecules may
indicate endothelial dysfunction (8). Interestingly, several
studies have reported that levels of these adhesion molecules
appeared to be increased in the serum of pregnant women
with preeclampsia (9-11). Indeed, abnormal levels of these
adhesion molecules may be considered to be markers of pree-
clampsia (9). However, reports are not always in agreement.
Lyall et al. (12) reported that serum levels of VCAM-1 and
E-selectin were not significantly different between normal and
preeclamptic pregnancies. Chaiworapongsa et al. (13) suggest-
ed that serum levels of ICAM-1 were no differences between
normal and preeclamptic pregnancies. 
In the present study, we compared the levels of soluble
VCAM-1 (sVCAM-1, CD106), ICAM-1 (sICAM-1, CD54)
and E-selectin (sE-selectin, CD62E) in the maternal serum
of normal and preeclamptic pregnancies. 
MATERIALS AND METHODS
Study subjects
The study population consisted of 63 women with normal
pregnancy, 33 women with mild preeclampsia, and 82 women
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Preeclampsia
Endothelial dysfunction is thought to be a central pathogenic feature in preeclampsia
on the basis of elevated adhesion molecules. The aim of the present study was to
compare the levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), inter-
cellular adhesion molecule-1 (sICAM-1) and E-selectin (sE-selectin) in sera of normal
and preeclamptic pregnancies. We studied the serum levels of sVCAM-1, sICAM-1
and sE-selectin in normal pregnant women (n=63), mild preeclampsia (n=33) and
severe preeclampsia (n=82). Concentrations of soluble adhesion molecules were
determined with enzyme-linked immunoassay (ELISA). Serum concentrations of
sVCAM-1 were significantly higher in both mild (p=0.004) and severe preeclampsia
(p=0.000) than normal pregnancy. There were also significant differences in sVCAM-
1 levels between mild and severe preeclampsia (p=0.002). sICAM-1 levels of severe
preeclampsia were statistically different from those of normal pregnancy (p=0.038).
Levels of sE-selectin were elevated in both mild (p=0.011) and severe preeclamp-
sia (p=0.000) compared to normal pregnancy, but no statistical difference between
the mild and severe preeclampsia (p=0.345). These results suggest that all three
soluble adhesion molecules are increased in severe preeclampsia, and sVCAM-1
among them may be useful in predicting the severity of preeclampsia.
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with severe preeclampsia. The clinical characteristics of the
study groups are shown in Table 1. Cases complicated by ch-
ronic hypertension, diabetes, chronic renal disease and autoim-
mune disorders were not included in the study. Preeclampsia
was defined as hypertension (systolic blood pressure ≥140
mmHg and diastolic blood pressure ≥90 mmHg after 20
weeks’ gestation) and proteinuria (≥300 mg in a 24 hr urine
collection or one dipstick measurement of ≥1+) according
to the Committee of Terminology of ACOG definition (14).
Severe preeclampsia was diagnosed on the basis of diastolic
blood pressure ≥110 mmHg or significant proteinuria (dip-
stick measurement of ≥2+) or the presence of severity evi-
dences such as headache, visual disturbances, upper abdom-
inal pain, oliguria, convulsion, elevated serum creatinine,
thrombocytopenia, marked liver enzyme elevation, and pul-
monary edema. Normal pregnant women had no hyperten-
sion, proteinuria, and edema.
Serum samples and assays of soluble adhesion molecules
Peripheral venous blood samples were collected in sterile
tubes containing ethylenediamine-tetraacetic acid (EDTA).
No drugs were taken by these patients for 24 hr before the
blood sampling. Blood collected in EDTA was immediately
stored at 4℃ and further processed within 48 hr. Samples
were centrifuged at 800 gfor 15 min and the supernatant was
stored in 200  L aliquots at -70℃. Serum levels of sVCAM-
1, sICAM-1 and sE-selectin were measured by commercial
ELISA assay (R&D Systems, Heidelberg, Germany) according
to the manufacture’s instructions. All experiments were per-
formed by an investigator blinded to the study groups assign-
ment. Samples were checked by serial dilution, and measure-
ments were performed at least in duplicate.
Statistical analysis
All data analyses were performed by means of the Statisti-
cal Package for the Social Science (SPSS version 10.0). Results
were expressed as a mean±standard deviation (SD). Differ-
ences among the three groups were compared with one-way
analysis of variance (ANOVA) and the post-hoc Bonferroni
correction method for multiple comparisons. Statistical sig-
nificance was assumed at a pvalue less than 0.05.
RESULTS
The clinical characteristics of the study groups are summa-
rized in Table 1. There were no differences in the maternal
age and platelet count among three groups. The gestational
ages at delivery (p=0.005 for mild preeclampsia; p=0.000 for
severe preeclampsia) and birth weights of the newborns (p=
0.000 for both) were significantly different between normal
pregnancy and preeclampsia groups. As expected, the blood
pressures were significantly higher in the preeclampsia groups
than in normal pregnancy (p=0.000, respectively). 
The serum concentrations of soluble adhesion molecules
are shown in Fig. 1. Level of sVCAM-1 was significantly
higher in both mild (960.71±364.7 ng/mL, p=0.004) and
severe preeclampsia (1,376.75±451.5 ng/mL, p=0.000) com-
pared with normal pregnancy (570.33±222.56 ng/mL) (Fig.
1A). Serum levels of sICAM-1 were not different statistically
between the mild preeclamptic pregnancies (282.38±121.14
ng/mL, p=0.181) and normal pregnancies (243.27±57.56
ng/mL), but the concentration was higher in severe preeclam-
psia (291±108.73 ng/mL, p=0.038) compared with nor-
mal pregnancy (Fig. 1B). For sE-selectin level, the mean
value was significantly elevated in both mild (52.40±27.42
ng/mL, p=0.011) and severe preeclampsia (61.94±36.8 ng/
mL, p=0.000) compared with normal pregnancy group (33.94
±16) (Fig. 1C). In preeclampsia groups, levels of sICAM-1
and sE-selectin were not different statistically between mild
and severe preeclamptic pregnancies (p=1.000 for sICAM-1;
p=0.345 for sE-selectin). Only sVCAM-1 level was different
significantly between the mild and severe preeclampsia (p=
0.002).
Characteristics pp * p
� Preeclampsia
NP (n=63) MPE (n=33) SPE (n=82)
Maternal age (yr) 30.8±3.0 29.8±3.6 30.8±4.0 0.558 1.000 0.551
Gestational age 
at delivery (wk) 39.2±1.0 37±2.9 35.3±4.2 0.005 0.000 0.041
Birth weight (g) 3372.2±382.3 2654.4±818.5 2167.3±855.4 0.000 0.000 0.024
Maximum systolic blood 
pressure (mm Hg) 127.9±10.5 147.3±17.3 162.8±15.9 0.000 0.000 0.036
Maximum diastolic blood  
pressure (mm Hg) 76.8±9.6 95.3±10.9 110.1±12.7 0.000 0.000 0.015
Platelet count (×10
3/ L) 242.3±47.2 236.6±76.7 227.91±82.6 1.000 0.699 1.000
Table 1. Clinical characteristics of normal pregnancy (NP), mild preeclampsia (MPE) and severe preeclampsia (SPE)
Data are given as mean±SD and were analyzed by ANOVA with multiple comparisons using the Bonferroni correction method. p, comparison between
normal pregnancy and mild preeclamsia; p*, comparison between normal pregnancy ad severe preeclampsia; p
�
, comparison between mild and severe
preeclampsia. 690 S.-Y. Kim, H.-M. Ryu, J.H. Yang, et al.
DISCUSSION
Preeclampsia is a pregnancy-specific disorder that is clini-
cally characterized by hypertension, proteinuria and edema
which remits after delivery. Despite the still unexplained
pathogenesis, preeclampsia is thought to be resulted from gen-
eralized endothelial dysfunction (15). Recently, increased lev-
els of cell adhesion molecules are believed to be indicators of
endothelial dysfunction in preeclampsia (16). The cell adhesion
molecules play a role in leukocyte-endothelial interaction and
are divided into three groups according to their structure: selec-
tins, integrins and members of the immunoglobulin gene super-
family. The selectins mediate the early steps (‘‘rolling’’) of
leukocyte adhesion to activated endothelial cell, while integrins
and the immunoglobulin gene superfamily regulate the sub-
sequent steps (firm adhesion followed by transmigration) (17).
VCAM-1 is a cell adhesion molecule and a member of the
immunoglobulin superfamily (18). VCAM-1 has a single chain
glycoprotein structure and functions as a transmembrane
receptor in vascular endothelial cell membranes. VCAM-1
is present on a number of activated cells, including activated
endothelial cells. Increased concentrations of VCAM-1 may
reflect increased expression of this molecule on the endothe-
lial surface. The expression of VCAM-1 on cells is regulated,
at least in part, by multiple microenvironmental influences,
such as changes in cytokine concentrations (19). For example,
VCAM-1 expression on endothelial cells is induced by inter-
leukin-1 , interleukin-4, tumor necrosis factor- , and inter-
feron gamma (20). VCAM-1 is important for recruiting leu-
kocytes to sites of inflammation because it mediates the adhe-
sion of lymphocytes, monocytes, and eosinophils to endothe-
lium (20). Our results indicated that circulating sVCAM-1
levels were significantly increased in severe preeclampsia com-
pared with mild preeclampsia or normal pregnancy. Lyall et al.
(21) were the first to show that sVCAM-1 was elevated in the
serum of preeclamptic patients. Krauss et al. (9) also found
significantly elevated levels of VCAM-1 in the plasma of preg-
nant women who subsequently developed preeclampsia, 3-15
weeks earlier before the onset of clinical symptoms. In con-
trast to these reports, Haller et al. (22) reported that ICAM-1
expression was increased in serum from preeclamptic patients
but VCAM-1 expression was not. 
ICAM-1 is a member of the immmunoglobulin superfamily
that mediates its functional activity through binding to leuko-
cyte 2-integrins (23). The ICAM-1 molecule is functionally
involved in the regulation of adhesion of leukocytes to the
endothelium as well as leukocyte migration (24). The molecule
expression is also essential for MHC (main histocompatibil-
ity complex) and non-MHC restricted cytotoxicity, interac-
tions between T and B lymphocytes, and mitogen and anti-
gen-induced lymphocyte proliferation (25). The shed soluble
form (sICAM) is also present in plasma and interferes as a reg-
ulatory factor in ICAM-1/ 2-integrin interactions (25). In
this study, sICAM-1 levels were elevated in severe preeclamp-
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Fig. 1. Concentrations of soluble VCAM-1 (A), ICAM-1 (B), and
E-selectin (C) in normal pregnancy (NP), mild preeclampsia (MPE)
and severe preeclampsia (SPE). *p<0.05, comparison with normal
pregnancy; 
� p<0.05, comparison with both normal pregnancy and
mild preeclampsia.
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sia compared with normal pregnancy but no difference bet-
ween mild preeclampsia and normal pregnancy. There were
no statistical differences in the levels of sICAM-1 between
mild and severe preeclampsia. Austgulen et al. (8) reported
significantly elevated ICAM serum levels in women with
preeclampsia. Djurovic et al. (23) also described that concen-
trations of ICAM-1 were slightly increased in preeclampsia.
Contrary to these reports, Phocas et al. (26) could not detect
an increased ICAM-1 serum level in preeclampsia. 
E-selectin is a member of the selectin family that is cytokine
inducible and largely restricted to endothelial cells. It medi-
ates the adhesion of various leukocytes, including neutrophils,
monocytes, eosinophils, natural killer cells, and a subset of
T cells, to activated endothelium (27). The expression of E-
selectin is induced in human endothelium in response to
cytokines such as interleukin-1 and tumor necrosis factor-
through transcriptional upregulation (28). We found that
serum concentrations of sE-selectin were significantly higher
in both mild and severe preeclampsia than normal pregnancy.
There were no statistical differences in the levels of sE-selectin
between mild and severe preeclampsia. Bersinger et al. (29)
suggested that the level of E-selectin in the serum of preeclam-
ptic women was within normal pregnancy ranges, whereas
Bretelle et al. (30) reported that sE-selectin was significantly
increased in preeclampsia compared with the normal controls.
In summary, we have determined the serum concentrations
of soluble adhesion molecule VCAM-1, ICAM-1 and E-selec-
tin in normal pregnancy and preeclampsia. All three adhesion
molecules are elevated in severe preeclampsia compared with
normal pregnancy, and sVCAM-1 among them may be use-
ful in predicting the severity of preeclampsia. The clinical
validity of the monitoring levels of these molecules needs to
be established in further studies. 
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